View Item 

Show simple item record

Comparative Chronic Valve and Venous Effects of Lumenless versus Stylet‐Delivered Pacing Leads in Patients with and Without Congenital Heart
dc.contributor.authorBharmanee, Apinyaen_US
dc.contributor.authorZelin, Kathleenen_US
dc.contributor.authorSanil, Yamunaen_US
dc.contributor.authorGupta, Poojaen_US
dc.contributor.authorKarpawich, Peter P.en_US
dc.date.accessioned2015-11-12T21:03:50Z
dc.date.available2017-01-03T16:21:17Zen
dc.date.issued2015-11en_US
dc.identifier.citationBharmanee, Apinya ; Zelin, Kathleen ; Sanil, Yamuna ; Gupta, Pooja ; Karpawich, Peter P. (2015). "Comparative Chronic Valve and Venous Effects of Lumenless versus Styletâ Delivered Pacing Leads in Patients with and Without Congenital Heart." Pacing and Clinical Electrophysiology 38(11): 1343-1350.en_US
dc.identifier.issn0147-8389en_US
dc.identifier.issn1540-8159en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/115920
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherpediatricsen_US
dc.subject.otherclinicalen_US
dc.subject.otherelectrophysiologyen_US
dc.subject.otherechocardiographyen_US
dc.subject.otherpacingen_US
dc.titleComparative Chronic Valve and Venous Effects of Lumenless versus Stylet‐Delivered Pacing Leads in Patients with and Without Congenital Hearten_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPhysiologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/115920/1/pace12728.pdf
dc.identifier.doi10.1111/pace.12728en_US
dc.identifier.sourcePacing and Clinical Electrophysiologyen_US
dc.identifier.citedreferenceBaumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Lung B, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009; 22: 1 – 23.en_US
dc.identifier.citedreferenceBracke F, Meijer A, Van Gelder B. Venous occlusion of the access vein in patients referred for lead extraction: Influence of patient and lead characteristics. Pacing Clin Electrophysiol 2003; 26: 1649 – 1652.en_US
dc.identifier.citedreferenceMelzer C, Lembcke A, Ziemer S, Eddicks S, Witte J, Baumann G, Borges AC. Pacemaker‐induced superior vena cava syndrome: Clinical evaluation of long‐term follow‐up. Pacing Clin Electrophysiol 2006; 29: 1346 – 1351.en_US
dc.identifier.citedreferenceSingh M, Talab SK. A case of pacing lead induced clinical superior vena cava syndrome: A case report. Cases J 2009; 2: 7477.en_US
dc.identifier.citedreferenceSenthilvel E, Papadakis A, Jain V, Bruner J. Pacemaker induced superior vena cava syndrome: A case report. Cases J 2009; 2: 6463.en_US
dc.identifier.citedreferenceKlop B, Scheffer MG, McFadden E, Bracke F, van Gelder B. Treatment of pacemaker‐induced superior vena cava syndrome by balloon angioplasty and stenting. Neth Heart J 2011; 19: 41 – 46.en_US
dc.identifier.citedreferenceKhan A, Zelin K, Karpawich PP. Performance of the lumenless 4.1‐Fr diameter pacing lead implanted at alternative pacing sites in congenital heart: A chronic 5‐year comparison. Pacing Clin Electrophysiol 2010; 33: 1467 – 1474.en_US
dc.identifier.citedreferenceGammage MD, Lieberman RA, Yee R, Manolis AS, Compton SJ, Khazen C, Schaaf K, et al. Multi‐center clinical experience with a lumenless, catheter‐delivered, bipolar, permanent pacemaker lead: Implant safety and electrical performance. Pacing Clin Electrophysiol 2006; 29: 858 – 865.en_US
dc.identifier.citedreferenceTuzcu V. Implantation of select secure leads in children. Pacing Clin Electrophysiol 2007; 30: 831 – 833.en_US
dc.identifier.citedreferenceKenny D, Walsh KP. Noncatheter‐based delivery of a single chamber lumenless pacing lead in small children. Pacing Clin Electrophysiol 2007; 30: 834 – 838.en_US
dc.identifier.citedreferenceChakrabarti S, Morgan GJ, Kenny D, Walsh KP, Oslizlok P, Martin RP, Turner MS, et al. Initial experience of pacing with a lumenless lead system in patients with congenital heart disease. Pacing Clin Electrophysiol 2009; 32: 1428 – 1433.en_US
dc.identifier.citedreferenceGarnreiter J, Whitaker P, Pilcher T, Etheridge S, Saarel E. Lumenless pacing leads: Performance and extraction in pediatrics and congenital heart disease. Pacing Clin Electrophysiol 2015; 38: 42 – 47.en_US
dc.identifier.citedreferenceGabbarini F, Agnoletti G. Selective‐site pacing in paediatric patients: Use of the SelectSecure System and risk of vein occlusion. Europace 2010; 12: 1286 – 1289.en_US
dc.identifier.citedreferenceZoghbi WA, Enriquez‐Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two‐dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16: 777 – 778.en_US
dc.identifier.citedreferenceSanjeev S, Karpawich PP. Superior vena cava and innominate vein dimension in growing children: An aid for interventional devices and transvenous leads. Pediatr Cardiol 2006; 27: 414 – 418.en_US
dc.identifier.citedreferenceFiga FH, McCrindle BW, Bigras JL, Hamilton RM, Gow RM. Risk factors for venous obstruction in children with transvenous pacing leads. Pacing Clin Electrophysiol 1997; 20: 1902 – 1909.en_US
dc.identifier.citedreferenceKarpawich PP, Singh H, Zelin K. Optimizing paced ventricular function in patients with and without repaired congenital heart disease by contractility‐guided lead implant. Pacing Clin Electrophysiol 2014; 38: 54 – 62.en_US
dc.identifier.citedreferenceDeshmukh P, Casavant D, Romanyshyn M, Anderson K. Permanent, direct His‐bundle pacing. A novel approach to cardiac pacing in patients with normal His‐Purkinje activation. Circulation 2000; 101: 869 – 877.en_US
dc.identifier.citedreferenceKapa S, Bruce C, Friedman P, Asirvatham S. Advances in cardiac pacing: Beyond the transvenous right ventricular apical lead. Cardiovasc Ther 2010; 28: 369 – 379.en_US
dc.identifier.citedreferenceCantù F, De Filippo P, Gabbarini F, Borghi A, Brambilla R, Ferrero P, Comisso J, et al. Selective‐site pacing in paediatric patients: A new application of the Select Secure system. Europace 2009; 11: 601 – 606.en_US
dc.identifier.citedreferenceDaccarett M, Segerson NM, Bradley DJ, Etheridge SP, Freedman RA, Saarel EV. Bipolar lumenless lead performance in children and adults with congenital heart disease. Congenit Heart Dis 2010; 5: 149 – 156.en_US
dc.identifier.citedreferencePatel S, Shah D, Chintala K, Karpawich PP. Clinically unrecognized atrial baffle complications following the Mustard operation in young adults with D‐transposition of the great arteries: Improved detection is required. Congenit Heart Dis 2011; 6: 466 – 474.en_US
dc.identifier.citedreferenceSakai M, Ohkawa S, Ueda K, Kin H, Watanabe C, Matsushita S, Kuramoto K, et al. Tricuspid regurgitation induced by transvenous right ventricular pacing: Echocardiographic and pathological observations. J Cardiol 1987; 17: 311 – 320.en_US
dc.identifier.citedreferencePaniagua D, Aldrich HR, Lieberman EH, Lamas GA, Agatston AS. Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads. Am J Cardiol 1998; 82: 1130 – 1132.en_US
dc.identifier.citedreferenceLin G, Nishimura RA, Connolly HM, Dearani JA, Sundt TM 3rd, Hayes DL. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter defibrillator leads. J Am Coll Cardiol 2005; 45: 1672 – 1675.en_US
dc.identifier.citedreferenceKim JB, Spevack DM, Tunick PA, Bullinga JR, Kronzon I, Chinitz LA, Reynolds HR. The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: An observational study. J Am Soc Echocardiogr 2008; 21: 284 – 287.en_US
dc.identifier.citedreferenceAl‐Bawardy R, Krishnaswamy A, Bhargava M, Dunn J, Wazni O, Tuzcu EM, Stewart W, et al. Tricuspid regurgitation in patients with pacemakers and implantable cardiac defibrillators: A comprehensive review. Clin Cardiol 2013; 36: 249 – 254.en_US
dc.identifier.citedreferenceWebster G, Margossian R, Alexander ME, Cecchin F, Triedman JK, Walsh EP, Berul CI. Impact of transvenous ventricular pacing leads on tricuspid regurgitation in pediatric and congenital heart disease patients. J Interv Card Electrophysiol 2008; 21: 65 – 68.en_US
dc.identifier.citedreferenceDa Costa SS, Scalabrini NA, Costa R, Caldas JG, Martinelli FM. Incidence and risk factors of upper extremity deep vein lesions after permanent transvenous pacemaker implant: A 6‐month follow‐up prospective study. Pacing Clin Electrophysiol 2002; 25: 1301 – 1306.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
pace12728.pdf
Size:
353.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.